{"adverse_reactions":["Sincerus Florida, LLC. Adverse reactions sw"],"components":["Active, inactive r"],"effective_time":"20190510","id":"8889353c-eb02-f8f3-e053-2995a90a60d4","instructions_for_use":["Directions for use s"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-1014-2 BENZOYL PEROXIDE USP 5% / CLINDAMYCIN USP 1% / NIACINAMIDE USP 2% / SPIRONOLACTONE USP 2%. Gel 30gm ad"],"set_id":"8889353c-eb01-f8f3-e053-2995a90a60d4","spl_product_data_elements":["BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / SPIRONOLACTONE 2% BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / SPIRONOLACTONE 2% BENZOYL PEROXIDE BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE CLINDAMYCIN NIACINAMIDE NIACINAMIDE SPIRONOLACTONE SPIRONOLACTONE"],"version":"1"}